The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Open accessAbstract
Dementia with Lewy bodies (DLB) was considered to be an uncommon cause of dementia until improved neuropathological staining methods for ubiquitin were developed in the late 1980's. Subsequent recognition that 10-15% of dementia cases in older people were associated with Lewy body pathology led to the publication in 1996 of Consensus clinical and pathological diagnostic criteria for the disorder. These have greatly raised global awareness of DLB and helped to generate a body of knowledge which informs modern clinical management of this pharmacologically sensitive group of patients. They have also enabled important issues surrounding the relationships of DLB with Alzheimer's disease and Parkinson's disease to be addressed and partially resolved. A recent re-evaluation of the Consensus criteria has confirmed many aspects of the original recommendations, supplementing these with suggestions for improved pathological characterisation, clinical detection and management. Virtu-ally unrecognised 20 years ago, DLB could within this decade be one of the best characterised and potentially treatable neurodegenerative disorders of late life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationThe Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
McKeith, I., Fairbairn, A., Perry, R., Thompson, P., & Perry, E. (1992) · BMJ · doi:10.1136/bmj.305.6855.673 · Cited by 624
Self-citationKosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Diffuse Lewy body disease: clinical features in 15 cases.
Byrne, E. J., Lennox, G., Lowe, J., & Godwin-Austen, R. B. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.6.709 · Cited by 311
CLINICAL AND PATHOLOGICAL FEATURES OF DIFFUSE CORTICAL LEWY BODY DISEASE (LEWY BODY DEMENTIA)
GIBB, W. R. G., ESIRI, M. M., & LEES, A. J. (1987) · Brain · doi:10.1093/brain/110.5.1131 · Cited by 260
Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias
Lopez, O. L., Litvan, I., Catt, K. E., Stowe, R., Klunk, W., Kaufer, D. I., Becker, J. T., & DeKosky, S. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1292 · Cited by 236
Lewy bodies in cerebral cortex. Report of three cases
Kosaka, K. (1978) · Acta Neuropathologica · doi:10.1007/bf00690978 · Cited by 234
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia
O’Brien, J. T., Paling, S., Barber, R., Williams, E. D., Ballard, C., McKeith, I. G., Gholkar, A., Crum, W. R., Rossor, M. N., & Fox, N. C. (2001) · Neurology · doi:10.1212/wnl.56.10.1386 · Cited by 215
Self-citationNeuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease
Ballard, C., Grace, J., McKeith, L., & Holmes, C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78999-6 · Cited by 209
Diffuse Lewy body disease and progressive dementia
Burkhardt, C. R., Filley, C., Kleinschmidt-DeMasters, B. K., de la Monte, S., Norenberg, M. D., & Schneck, S. A. (1988) · Neurology · doi:10.1212/wnl.38.10.1520 · Cited by 185
Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
Lennox, G., Lowe, J., Landon, M., Byrne, E. J., Mayer, R. J., & Godwin-Austen, R. B. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.11.1236 · Cited by 184
CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY-SEVEN CASES
Woodard, J. S. (1962) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196207000-00012 · Cited by 130
Lewy bodies and response to tacrine in Alzheimer's disease
Levy, R., Eagger, S. A., Griffiths, M., Perry, E. K., Honavar, M., Dean, A. F., & Lantos, P. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90966-0 · Cited by 120
The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT)
McKeith, I. G., FAIRBAIRN, A. F., Perry, R. H., & Thompson, P. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.3.324 · Cited by 119
Self-citationAtrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: An MRI study
Cousins, D. A., Burton, E. J., Burn, D. J., Gholkar, A. R., McKeith, I. G., & O'Brien, J. T. (2003) · Neurology · doi:10.1212/01.wnl.0000091889.20347.30 · Cited by 114
Self-citationCLINICALLY AND NEUROPATHOLOGICALLY DISTINCT FORM OF DEMENTIA IN THE ELDERLY
Perry, R. H., Irving, D., Blessed, G., Perry, E. K., & FAIRBAIRN, A. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91187-2 · Cited by 104
Parkinson's disease and dementia with Lewy bodies: a difference in dose?
Singleton, A., & Gwinn, K. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17117-1 · Cited by 87
Hallucinations Predict Attentional Improvements with Rivastigmine in Dementia with Lewy Bodies
McKeith, I. G., Wesnes, K. A., Perry, E. K., & Ferrara, R. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077816 · Cited by 82
Self-citationSNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies
Johnson, J. O., Hague, S., Hanson, M., Gibson, A., Wilson, K., Evans, E. W., Singleton, A., McInerney-Leo, A. M., Nussbaum, R. L., Hernandez, D. G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000133401.09043.44 · Cited by 75
Self-citationLewy body pathology is a frequent co-pathology in familial Alzheimer's disease
Trembath, Y., Rosenberg, C., Ervin, J. F., Schmechel, D. E., Gaskell, P. C., Pericak‐Vance, M. A., Vance, J. M., & Hulette, C. M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0670-9 · Cited by 42
Tacrine for senile dementia of Alzheimer's or Lewy body type
Wilcock, G., & Scott, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91933-x · Cited by 41
Dementia with Lewy bodies: Improving diagnostic criteria
Lippa, C. F., & McKeith, I. G. (2003) · Neurology · doi:10.1212/01.wnl.0000066054.20031.b0 · Cited by 27
Self-citationGwinn, K. A., & Singleton, A. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500407 · Cited by 17
Cited by
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
“Last, as mentioned above, the single most important neuropathological finding that distinguishes PDD from DLB is the presence of Ab deposits in the striatum (Duda et al. 2002) and in the hippocampus (Masliah et al. 1993a).”
InfluentialAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Metadata
- Authors
- McKeith, I. G.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2006-07-27
- Volume
- 9
- Issue
- s3
- Pages
- 417-423
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W74129954
- Cited by
- 625
- References
- 25
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.